Orianna Bretschger received a B.S. in Physics and Astronomy at the University of Northern Arizona; and after a career in aerospace and government consulting, she completed a Ph.D. in Materials Science at the University of Southern California. Bretschger launched Aquacycl with her partners after 12 years of technological development and validation. Dr. Bretschger is a 2021 Cartier Women’s Initiative Science and Technology Pioneer Laureate, a 2019 Fellow in the National Academy of Sciences New Voices in Science, Engineering and Medicine Program, a 2022 Unreasonable Fellow, and Aquacycl was a Finalist for the 2023 Earthshot Prize for their work to decarbonize wastewater treatment.
Aquacycl was founded in November 2016 and the company provides industrial wastewater treatment as a service to help companies support healthy watersheds and communities world-wide with offices in the United States and Aquacycl Europe B.V. in the Netherlands. Aquacycl technologies and services guarantee permit compliance, greenhouse gas mitigation, reliable performance in variable production environments, and operational savings. Customers served by Aquacycl, including PepsiCo, have realized up to a 30% reduction in wastewater management costs and over 100 tons of greenhouse gas emissions mitigated per month.
Tiphaine is an Associate Director within the Carbon Trust’s Business Services team. She provides advice to corporates in the Agriculture Food and Drink sector with a key focus on the Livestock and Dairy subsectors whilst also supporting global food and drinks brands. Tiphaine specialises in advising on footprinting, target setting and transition planning within the sector, as well as leading the Carbon Trust’s Product Carbon Footprint Label offering.
Kaitlin has been with Oximio BARL Canada for more than 10 years. As Managing Director, she oversees the planning, direction, and management of operations, while also guiding the organization’s strategic vision and future growth.
She holds a Bachelor of Arts from Brock University, a Pharmacy Technician Diploma from Niagara College, and an MBA from Athabasca University. With this diverse academic background, Kaitlin ensures that operations run compliantly, efficiently, and with customer care at the forefront.
Erin Gunduz is a senior Quality and Regulatory Affairs leader in the in vitro diagnostics and medical device space, with deep experience across IVDR, MDR and FDA regulatory frameworks. She focuses on building modular, pragmatic, and risk-based strategies to enable successful product development and lifecycle maintenance, while advocating the role of compliance as the foundation for confident and evidence-driven decision-making.
Dynamic and experienced leader with a proven track record of guiding teams and managing complex projects to achieve strategic objectives in both local and global settings. Excels at identifying and resolving challenges, designing sustainable solutions, and maintaining high standards while ensuring alignment with organizational goals. Demonstrated expertise in strategic planning, project and change management, and problem-solving, with a strong focus on driving continuous improvement and delivering impactful results.
Leslie Pibouleau works as a policy officer in the European Commission in the Unit of the Directorate General for Health and Food Safety (DG SANTE) in charge of the State of Health, the European Semester, and Health Technology Assessment. Leslie is a biomedical engineer by background with a PhD in public health on statistical methods for medical devices. She has been working on medical devices and their clinical evaluation in many different capacities since 2000, both in the private and the public sector: Medtech companies, Contract Research Organisations, the French HTA body (Haute Autorité de Santé), the European Medicines Agency where she kickstarted the work of the expert panels secretariat as well as the European Commission where she currently works on the implementation of the HTA Regulation.
Sophie graduated from the University of Liverpool with a BSc in Biological Sciences in 2022. She has since completed a master’s in Clinical Drug Development at University College London, where she undertook a dissertation looking at the differences in the clinical presentation between adults and pediatrics with systemic lupus erythematosus. Following on from this, Sophie has a strong interest in the medical sectors.
